UM

Browse/Search Results:  1-3 of 3 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials Journal article
EXPERT OPINION ON DRUG SAFETY, 2016,Volume: 15,Issue: 5,Page: 591-612
Authors:  Galling, B;  Roldan, A;  Rietschel, L;  Hagi, K;  Walyzada, F;  Zheng, W;  Cao, XL;  Xiang, YT;  Kane, JM;  Correll, CU
Favorite  |  View/Download:2/0  |  Submit date:2019/01/07
Monotherapy  Metaanalysis  Antipsychotics  Augmentation  Combination  Polypharmacy  Cotreatment  Adverse Effects  Tolerability  Safety  Schizophrenia  
Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia Journal article
Epidemiology and Psychiatric Sciences, 2016,Volume: 25,Issue: 1,Page: 9-17
Authors:  Y.-T. Xiang;  G. S. Ungvari;  C. U. Correll;  H. F. K. Chiu;  N. Shinfuku
Favorite  |  View/Download:2/0  |  Submit date:2019/01/07
Asia, , Psychotropic  Schizophrenia  Prescription Patterns  Medications  
Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China Journal article
International Journal of Clinical Pharmacology and Therapeutics, 2016,Volume: 54,Issue: 1,Page: 36-42
Authors:  Hou C.-L.;  Ma X.-R.;  Zang Y.;  Jia F.-J.;  Lin Y.-Q.;  Chiu H.F.K.;  Ungvari G.S.;  Ng C.H.;  Zhong B.-L.;  Cao X.-L.;  Li Y.;  Cai M.-Y.;  Xiang Y.-T.
Favorite  |  View/Download:2/0  |  Submit date:2018/12/18
Antipsychotic Polypharmacy  China  Community-dwelling  Schizophrenia